Xilio Therapeutics Inc. (XLO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.08
0.00 (0.00%)
At close: Jan 15, 2025, 12:35 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
PE Ratio | -0.2 | -0.84 | -5.89 | -7.96 | -25.39K |
PS Ratio | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.41 | 0.70 | 2.36 | -5.28 | -14.89K |
P/FCF Ratio | -218.83 | -0.95 | -5.35 | -11.48 | -23.68K |
P/OCF Ratio | -0.22 | -0.97 | -5.42 | -12.18 | -24.63K |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.31 | 0.19 | 0.11 | -0.25 | -0.63 |
Quick Ratio | 3.02 | 5.89 | 15.85 | 0.93 | 9.81 |
Current Ratio | 3.02 | 5.89 | 15.85 | 0.93 | 9.81 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | -125.07 | -90.94 | n/a |
Return on Equity (ROE) | -2.07 | -0.83 | -0.4 | 0.66 | 0.59 |
Return on Assets (ROA) | -1.25 | -0.63 | -0.34 | -1.52 | -0.28 |
Return on Capital (ROIC) | -1.76 | -0.76 | -0.37 | -3.85 | -0.33 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a |